Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000178 · ClinicalTrials.gov registry record · Phase 3
Multicenter Trial of Prednisone in Alzheimer's Disease
A Phase 3 study, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- Phase 3
- Development phase
NCT00000178 is a Phase 3 study that has completed, run by National Institute on Aging (NIA).
The verdict
NCT00000178, a Phase 3 study, has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
This is a randomized placebo controlled, double blind study. Patients who meet eligibility criteria and decide to participate in the study will be randomly assigned to receive either drug treatment or a placebo. Neither the patients nor the participating investigators will know who is receiving the drugs and who is receiving the placebo. Participation involves 15 outpatient clinic visits over a 68 week period. Patients take study medication at varying doses (the maximum dose is 20 mg daily), along with calcium and vitamin supplements.
Interventions
- DRUG Prednisone
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000178
The ClinicalTrials.gov registry entry for NCT00000178 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute on Aging (NIA), which has 131 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prednisone is the first listed.
NCT00000178 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000178 about?
NCT00000178 is a clinical study titled "Multicenter Trial of Prednisone in Alzheimer's Disease". This is a randomized placebo controlled, double blind study. Patients who meet eligibility criteria and decide to participate in the study will be randomly assigned to receive either drug treatment or a placebo. Neither the patients nor the participating investigators will know who is receiving the ...
What is the current status of trial NCT00000178?
This trial is currently completed. It is a Phase 3 study.
What interventions are being tested in trial NCT00000178?
The interventions under investigation include: Prednisone (DRUG).
Who is sponsoring clinical trial NCT00000178?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.